Genetic variants of TCF7L2 correlate with susceptibility to type 2 diabetes [8, 21] and Crohn’s disease [29, 30] and the aberrant expression of TCF7L2 has also been linked to the risk of cancer [7, 14]. Here, TCF7L2 is linked to Crohn disease.